References
Rare complication with sulindac,FDA Drug Bull 19, 4 (1989).
Paulus HE, FDA arthritis advisory committee meeting: serious gastrointestinal toxicity of nonsteroidal antiinflammatory drugs; drug-containing renal and biliary stones; diclofenac and carprofen approved,Arthritis Rheum 31, 1450–1451 (1988).
Ito S, Nozawa S, Ishikawa Het al., Renal stones in rheumatoid arthritis patients,J Rheumatol 24, 2123–2128 (1997).
Aratani M, Tanabashi S, Takakuwa Eet al., A general status of the health consultation center of this hospital during these 3 years (1987 to 1989),Takayama Red Cross Hospital Kiyou 14, 14–46 (1990).
Steinbrocker O, Traeger CH, Batterman RC, Therapeutic criteria in rheumatoid arthritis,J Am Med Ass 140, 659–662 (1949).
Author information
Authors and Affiliations
About this article
Cite this article
Ito, S., Hasegawa, H., Nozawa, S. et al. Sulindac usage may not be associated with an increased incidence of renal stone formation in patients with rheumatoid arthritis. Japanese Journal of Rheumatology 9, 119–121 (1999). https://doi.org/10.1007/BF03041268
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03041268